Effects of 8-week Theracurmin Super (TS-P1; curcumin) supplementation on exercise-induced oxidative stress: A randomized double-blind, placebo-controlled parallel clinical trial

Background: Given the antioxidant properties of curcumin, this study aimed to determine the effectiveness and safety of Theracurmin Super supplementation in mitigating exercise-induced oxidative stress in healthy adults. Methods: Seventy-one healthy adults participated in this study, which was condu...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinxing Li, Dae Young Kim, Yunho Sung, Donghyun Kim, Seohyun Ahn, Hyejung Shin, Nur Afiqah Binti Zulkifli, Ji-won Seo, Shu Jiang, Parivash Jamrasi, SoYoung Ahn, Jun Hyun Bae, HeeKyung Yeo, Hayoung Park, Wook Song
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Integrative Medicine Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213422024000799
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Given the antioxidant properties of curcumin, this study aimed to determine the effectiveness and safety of Theracurmin Super supplementation in mitigating exercise-induced oxidative stress in healthy adults. Methods: Seventy-one healthy adults participated in this study, which was conducted at Seoul National University from April 2022 to March 2023. Eligibility was determined during visit 1 through maximum oxygen consumption assessed using the Bruce Treadmill protocol. At visit 2, the participants were randomly allocated to either the Theracurmin Super supplement group (TG, n = 36) or the placebo supplement group (PG, n = 35). Over 8 weeks, the participants consumed Theracurmin Super (curcumin, 120 mg/day) or Placebo (curcumin, 0 mg/day) twice daily and visited the laboratory four times. Various parameters, including body composition, vital signs, nutrition quotient for adults, cardiorespiratory endurance, blood biomarkers, and adverse events, were assessed at each visit. Statistical analyses included per-protocol analysis, t-tests for group and within-group differences, and two-way ANOVA. Results: At week 8, blood biomarkers linked to oxidative stress, including TBARs, MDA, 8-OHdG, SOD, TOS, and OSI, showed significant group- and week-related interactions (total oxidant status: resting state P = 0.021; oxidative stress index, resting state P = 0.020, end of exercise, P = 0.013). Notably, the TG showed a significant decrease in total oxidant status (resting state P = 0.041) and oxidative stress index (resting state P = 0.018 and end of exercise P = 0.008) between weeks 0 and 8. However, MDA and 8-OHdG levels did not show statistically significant changes. Conclusions: Theracurmin Super effectively reduced oxidative stress before and after exercise, highlighting the promising role of curcumin in managing oxidative stress. Significant improvements in TOS and OSI were observed, although changes in MDA and 8-OHdG levels were not statistically significant. Further research could provide insights into these mixed results across different oxidative biomarkers. Trial registration: Clinical Research Information Service (CRIS): KCT0008731.
ISSN:2213-4220